South San Francisco, CA, United States of America

Xuan Zhao

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Ngm Biopharmaceuticals, Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xuan Zhao. Retrieved from https://idiyas.com/inventor/xuan-zhao-ev837j4w

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Xuan Zhao: Innovator in Binding Agents

Introduction

Xuan Zhao is a prominent inventor based in South San Francisco, CA. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of binding agents that target LAIR-1.

Latest Patents

Xuan Zhao holds a patent for LAIR-1-binding agents and methods of use thereof. This patent provides binding agents, such as antibodies, that specifically bind LAIR-1, including human LAIR-1. The disclosure also includes compositions comprising these binding agents, methods of their use, related polynucleotides, vectors encoding the binding agents, and cells that incorporate these binding agents. He has 1 patent to his name.

Career Highlights

Xuan Zhao is currently employed at NGM Biopharmaceuticals, Inc., where he continues to advance his research and development efforts in the biopharmaceutical sector. His work focuses on innovative solutions that can lead to significant medical advancements.

Collaborations

Xuan Zhao collaborates with talented professionals in his field, including Suzanne Christine Crawley and Bin Fan. Their combined expertise contributes to the success of their projects and the advancement of biopharmaceutical research.

Conclusion

Xuan Zhao is a dedicated inventor whose work in binding agents has the potential to impact the medical field significantly. His contributions to NGM Biopharmaceuticals, Inc. and his innovative patent highlight his commitment to advancing biopharmaceutical research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…